Vertex Pharmaceuticals Incorporated (BVMF:VRTX34)

Vertex Pharmaceuticals Statistics

Total Valuation

BVMF:VRTX34 has a market cap or net worth of BRL 609.54 billion. The enterprise value is 555.18 billion.

Market Cap	609.54B
Enterprise Value	555.18B

Important Dates

The next estimated earnings date is Monday, May 4, 2026.

Earnings Date	May 4, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.04%
Shares Change (QoQ)	-0.58%
Owned by Insiders (%)	0.21%
Owned by Institutions (%)	94.94%
Float	253.24M

Valuation Ratios

The trailing PE ratio is 27.99 and the forward PE ratio is 23.54.

PE Ratio	27.99
Forward PE	23.54
PS Ratio	9.22
PB Ratio	5.93
P/TBV Ratio	6.45
P/FCF Ratio	34.65
P/OCF Ratio	30.47
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.55, with an EV/FCF ratio of 31.56.

EV / Earnings	25.50
EV / Sales	8.75
EV / EBITDA	20.55
EV / EBIT	22.41
EV / FCF	31.56

Financial Position

The company has a current ratio of 2.90, with a Debt / Equity ratio of 0.11.

Current Ratio	2.90
Quick Ratio	2.24
Debt / Equity	0.11
Debt / EBITDA	0.40
Debt / FCF	0.64
Interest Coverage	352.44

Financial Efficiency

Return on equity (ROE) is 22.54% and return on invested capital (ROIC) is 29.61%.

Return on Equity (ROE)	22.54%
Return on Assets (ROA)	12.16%
Return on Invested Capital (ROIC)	29.61%
Return on Capital Employed (ROCE)	21.52%
Weighted Average Cost of Capital (WACC)	5.88%
Revenue Per Employee	10.33M
Profits Per Employee	3.40M
Employee Count	6,400
Asset Turnover	0.50
Inventory Turnover	3.85

Taxes

In the past 12 months, BVMF:VRTX34 has paid 3.80 billion in taxes.

Income Tax	3.80B
Effective Tax Rate	14.86%

Stock Price Statistics

The stock price has decreased by -16.15% in the last 52 weeks. The beta is 0.32, so BVMF:VRTX34's price volatility has been lower than the market average.

Beta (5Y)	0.32
52-Week Price Change	-16.15%
50-Day Moving Average	616.79
200-Day Moving Average	602.17
Relative Strength Index (RSI)	46.47
Average Volume (20 Days)	1,339

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.15

Income Statement

In the last 12 months, BVMF:VRTX34 had revenue of BRL 66.10 billion and earned 21.77 billion in profits. Earnings per share was 84.38.

Revenue	66.10B
Gross Profit	35.47B
Operating Income	25.82B
Pretax Income	25.57B
Net Income	21.77B
EBITDA	26.80B
EBIT	25.82B
Earnings Per Share (EPS)	84.38

Balance Sheet

The company has 36.40 billion in cash and 11.21 billion in debt, with a net cash position of 56.65 billion.

Cash & Cash Equivalents	36.40B
Total Debt	11.21B
Net Cash	56.65B
Net Cash Per Share	n/a
Equity (Book Value)	102.81B
Book Value Per Share	404.78
Working Capital	40.43B

Cash Flow

In the last 12 months, operating cash flow was 20.00 billion and capital expenditures -2.41 billion, giving a free cash flow of 17.59 billion.

Operating Cash Flow	20.00B
Capital Expenditures	-2.41B
Depreciation & Amortization	948.97M
Net Borrowing	-28.69M
Free Cash Flow	17.59B
FCF Per Share	n/a

Margins

Gross margin is 53.67%, with operating and profit margins of 39.06% and 32.94%.

Gross Margin	53.67%
Operating Margin	39.06%
Pretax Margin	38.69%
Profit Margin	32.94%
EBITDA Margin	40.55%
EBIT Margin	39.06%
FCF Margin	26.61%

Dividends & Yields

BVMF:VRTX34 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.04%
Shareholder Yield	-0.04%
Earnings Yield	3.57%
FCF Yield	2.89%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BVMF:VRTX34 has an Altman Z-Score of 11.93 and a Piotroski F-Score of 6.

Altman Z-Score	11.93
Piotroski F-Score	6